Valneva SE (“Valneva” or “the Company”), a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical […]
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, after conducting the final efficacy analysis in their […]
TrialSite reported recently that Moderna’s COVID-19 vaccine candidate known as mRNA-1273 fared quite well thus far based on an interim analysis […]
Pakistan, the fifth most populous nation in the world, recently geared up to support a Phase 3 COVID-19 vaccine clinical […]
U.S. Ambassador to the UAE, John Rakolta Jr., and others paid a visit to the Abu Dhabi Health Service company […]
TrialSite was the “US watchdog” referenced to by Jeremaiah M. Opinano in a recent Aug. 12 article in The Filipino […]
Novavax Inc. (Nasdaq: NVAX) has progressed their investigational vaccine product for COVID-19 called NVX-CoV2373 to Phase 3 to evaluate the […]
The COVID-19 pandemic has moved into India in a big way as that country becomes the second most impacted worldwide […]
“Project Lightspeed” has arrived in Hawai’i where the East-West Medical Research Institute was selected by Pfizer (and partner BioNTech) to […]
Dr. Amy Santengelo, working at Womack Army Medical Center for nearly 20 years, has been actively looking to participate in […]
